JM

Jean-Claude Mazie

IP Institut Pasteur: 11 patents #53 of 1,210Top 5%
CN CNRS: 4 patents #613 of 11,908Top 6%
Overall (All Time): #424,349 of 4,157,543Top 15%
12
Patents All Time

Issued Patents All Time

Showing 1–12 of 12 patents

Patent #TitleCo-InventorsDate
7704490 Method for inducing selected useful activities of IL-2 in a patient with peptides from IL-2 Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose +1 more 2010-04-27
7662368 Method of inducing SHC phosphorylation of inducing the SHC/MAPK pathway by administering a peptide of IL-2 Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose +1 more 2010-02-16
7101965 Peptides of IL-2 Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose +1 more 2006-09-05
6929791 Peptides of IL-2 and derivatives thereof Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Goldberg, Thierry Rose +1 more 2005-08-16
6825334 Peptides of IL-2 and derivatives thereof and their use as therapeutic agents Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau, Michel Golberg, Thierry Rose +1 more 2004-11-30
6770743 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury Christine Petit, Nadia Soussi-Yanticostas, Jean-Pierre Hardelin, Catherine Sarailh, Genevieve Rougon +2 more 2004-08-03
6596853 DNA encoding peptides of IL-2 Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau 2003-07-22
6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof Roselyne Tournaire, Caroline Demangel, Claude Derbin, Gerard Perret, Jean Plouet +1 more 2003-05-06
6548475 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuronal and neural injury Christine Petit, Nadia Soussi-Yanticostas, Jean-Pierre Hardelin, Catherine Sarailh, Genevieve Rougon +2 more 2003-04-15
6168785 Biological applications of new peptides of IL-2 and derivatives and use as therapeutic agents Jacques Theze, Ralph Eckenberg, Jean-Louis Moreau 2001-01-02
6121231 Use of the KAL protein and treatment with the KAL protein in treatment of retinal, renal, neuromal and neural injury Christine Petit, Nadia Soussi-Yanticostas, Jean-Pierre Hardelin, Catherine Sarailh, Genevieve Rougon +2 more 2000-09-19
4900661 Method for immunological determination of amines, monoclonal antibodies and kit of reagents for carrying out the method Jean-Luc Guesdon, Stratis Avrameas 1990-02-13